Merestinib

Unknown Manufacturer

Merestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal Cancer, and Metastatic Cancer, among others.

Generate AI report

Overview

Merestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal Cancer, and Metastatic Cancer, among others.

Technical identifiers

Chemical Formula: C₃₀H₂₂F₂N₆O₃
CAS Number: 1206799-15-6
UNII ID: 5OGS5K699E

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

AGENTS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOMA
EP 4117787 A4Applicant: UNIV CINCINNATIPriority: 2021
EP
US
3 publications
COMBINATION OF RAMUCIRUMAB AND MERESTINIB FOR USE IN TREATMENT OF COLORECTAL CANCER
CN 109069632 AApplicant: LILLY CO ELIPriority: 2016
CN
COMBINATION THERAPY WITH MERESTINIB AND ANTI-PD-L1 OR ANTI-PD-1 INHIBITORS FOR USE IN THE TREATMENT OF CANCER
CN 109562282 AApplicant: LILLY CO ELIPriority: 2016
CN
COMBINATION THERAPY FOR CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE
CN 109963562 AApplicant: LILLY CO ELIPriority: 2016
CN
Application of mexatinib as copper death inhibitor in preparation of medicine for preventing and treating copper death related diseases
CN 119950502 AApplicant: BIG HEALTH RES INSTITUTE OF HEFEI INTEGRATED SCIENCES CENTERPriority: 2025
CN

Drugs